Abstract 2224A: A novel TNFRSF25 agonist, PTX35, synergizes with Gp96-Ig/OX40L-Ig to enhance effector and memory anti-tumor CD8+ T cell responses and delay tumor growth
Authors: Vikas Tahiliani, Patrick Dillon, Jayalakshmi Miriyala, Anh Trinh, Rahul R. Jasuja, Jeff Hutchins, Matthew M. Seavey